Similarly, shRNA-mediated TYRO3 inhibition in the HCT-116 and HT-29 colorectal cancer cell lines decreased migration and invasion and overexpression of TYRO3 in HT-29 cells was sufficient to enhance migration [35]. Here, TYRO3 is linked to colorectal cancer.